Innate Pharma IPHA
NASDAQ IPHA
$1.63 +0.03 (+1.87%)
At close: Sep 30, 2026 · 4:00 PM EDT

Innate Pharma (IPHA) Other Operating Expenses (2021 - 2025)

Updated

Innate Pharma (IPHA) posted Other Operating Expenses of $1,164 for the quarter ended Dec 31, 2025.

Analysis

Innate Pharma (IPHA) Other Operating Expenses (2021 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Innate Pharma's Other Operating Expenses came in at $1,130.

  • In prior years, Innate Pharma's Other Operating Expenses was $0.00 in the year ended Dec 31, 2023 and -$42.85 million in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Innate Pharma 149.95 Mn 149.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1,164.04
Jun 30, 2025 0.00
Jun 30, 2024 1,076.89
Jun 30, 2023 0.00
Jun 30, 2021 0.00
API Access

Innate Pharma Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=IPHA&period=max&api_key=YOUR_API_KEY